JCPyV miR-J1-5p in Urine of Natalizumab-Treated Multiple Sclerosis Patients
The use of Natalizumab in Multiple Sclerosis (MS) can cause the reactivation of the polyomavirus JC (JCPyV); this may result in the development of progressive multifocal leukoencephalopathy (PML), a rare and usually lethal disease. JCPyV infection is highly prevalent in worldwide population, but the...
שמור ב:
| Principais autores: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2021-03-01
|
| סדרה: | Viruses |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1999-4915/13/3/468 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|